Philip O'Connell is a Clinical Professor in Medicine. He is Director of the Centre for Transplant and Renal Research at the Westmead Institute and Director of Transplant Medicine and the Clinical Islet Transplant Program at Westmead Hospital. He is also President of The Transplantation Society.
Philip undertook a PhD in endothelial cell adhesion molecules at the University of Melbourne and had further training in transplant immunology as a postdoctoral research fellow with Professor Terry Strom, Harvard Medical School. His major research interests are in the development of islet transplantation as a main stream treatment for type 1 diabetes and the use of genomics as a marker of renal allograft dysfunction. He was a principle investigator of the NIH funded GOCAR study. He is director of the Australian Clinical Islet Transplant Consortium, which has undertaken Australia’s first multicentre clinical trial of islet transplantation.
Kidney disease, Nephrology, Transplantation, Diabetes
Obesity, Diabetes and Cardiovascular Disease, Infection and Immunological Conditions